Kate Hanna
executive
Kate Hanna is the director of communications at Novo Nordisk Canada, where she oversees communication strategies and public relations efforts for the company, particularly concerning its diabetes care products, including Ozempic.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Kate Hanna, director of communications at Novo Nordisk Canada, mentioned the stable supply of Ozempic for the Canadian market.
6